ArcDia / mariPOC

Funding 💰
Select investors Lifeline Ventures, Finnvera, Innovestor
Key people 🧑🤝🧑
- Aleksi Soini - Co-founder, SVP Strategy and Business and Development
- Janne Koskinen - Co-founder, CEO & CSO
- Niko Meltola - Operations Director
- Xiaoyu Hu - Account Manager & Product Specialist
- Soukka Jori - Chief Engineer
Highlights ⭐
- Solving the problem: Antibiotic resistance is a growing concern globally, with resistance being responsible for causing 23,000 deaths per year in the US alone. ArcDia's pipeline product portfolio includes mariAST (RUO), a solution for tackling antibiotic resistance by speeding up antimicrobial susceptibility testing.
- Real-time epidemiological surveillance: ArcDia's mariCloud is an online service for real-time epidemiological surveillance. The tool helps healthcare professionals monitor infection incidence in real time and enables improved pandemic and epidemic preparedness.
- Available worldwide: As of May 2023, mariPOC diagnostic solutions were available in more than 30 countries. 🔗
Video ▶️
Awards & Recognitions 🏆
- 2014 Frost & Sullivan Award for Point-of-Care Product Leadership 🔗
Last update:
May 23, 2023
Disclaimer: The content on this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances.